Bayer Aktiengesellschaft (0P6S.IL)

26,89 -0,01 (-0,02%) Alla chiusura: 07:01PM BST

Bayer Aktiengesellschaft

Kaiser-Wilhelm-Allee 1
Leverkusen 51368
Germany
49 214 30 1
https://www.bayer.com

Settore/i: Healthcare
Settore: Drug Manufacturers - General
Impiegati a tempo pieno: 96.931

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. William N. Anderson	Chairman of the Management Board & CEO	8,43M	N/D	1966
Mr. Wolfgang U. Nickl	CFO & Member of Management Board	1,98M	N/D	1969
Mr. Heiko W. J. Schipper	Member of Management Board & Pres of the Consumer Health Division	1,95M	N/D	1969
Mr. Stefan Oelrich	Head of the Pharmaceuticals Division & Member of the Board of Management	1,95M	N/D	1968
Mr. Rodrigo Santos	Member of Management Board & Pres of the Crop Science Division	2,17M	N/D	1973
Ms. Heike Prinz	Chief Talent Officer, Labor Director & Member of Management Board	1,33M	N/D	1964
Mr. Julio Triana	Member of Management Board & Pres of Consumer Health Division	N/D	N/D	1966
Dr. Sebastian Guth Ph.D.	Chief Operating Officer	N/D	N/D	N/D
Dr. Jost Reinhard	Head of Investor Relations	N/D	N/D	1972
Mr. Michael Preuss	Head of Communications, Gov. Relations and Corp. Brand	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in EUR.

Descrizione

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health. The Crop Science segment offers seeds, improved plant traits, innovative chemical and biological crop protection products, digital solutions, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration with Acuitas Therapeutics, Inc. to strengthen gene editing programs; Peking University in the area of basic pharmaceutical research; the Swiss Tropical and Public Health Institute in the development of the compound emodepside for the treatment of infection with soil-transmitted helminths; bit.bio Ltd. for the discovery and manufacture of regulatory T cells for use in creating therapeutics; Hologic, Inc. in the field of contrastenhanced-mammography solutions to improve diagnostic imaging for the detection of breast cancer; and Twist Bioscience Corporation centering around the research and development of antibody-based pharmaceuticals, as well as with CrossBay Medical Inc. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company has collaboration with Thermo Fisher Scientific. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Governance aziendale

L'ISS Governance QualityScore di Bayer Aktiengesellschaft al 1 aprile 2024 è 3. I criteri di valutazione fondamentali sono revisione: 10; Consiglio di Amministrazione: 2; diritti degli azionisti: 1; retribuzione: 2.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.